| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |